News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wentworth Kerry
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/02/2023 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 400,000 options to buy
@ $1.94, valued at
$776k
|
|
| 08/31/2022 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 252,000 options to buy
@ $2.93, valued at
$738.4k
|
|
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/19/2021 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 140,843 shares
@ $8.5, valued at
$1.2M
Disposed/sold 6,000 shares
@ $8.5, valued at
$51k
Disposed/sold 24,000 options to buy
@ $19.61, valued at
$470.6k
Disposed/sold 10,000 options to buy
@ $22.91, valued at
$229.1k
Disposed/sold 10,000 options to buy
@ $18.16, valued at
$181.6k
Disposed/sold 20,000 options to buy
@ $18.2, valued at
$364k
Disposed/sold 35,000 options to buy
@ $18.56, valued at
$649.6k
Disposed/sold 33,333 options to buy
@ $22.31, valued at
$743.7k
Disposed/sold 18,000 options to buy
@ $14.75, valued at
$265.5k
Disposed/sold 15,500 options to buy
@ $15.78, valued at
$244.6k
Disposed/sold 20,000 options to buy
@ $11.41, valued at
$228.2k
|
|
| 07/20/2021 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Sold 3,944 shares
@ $6.45, valued at
$25.4k
|
|
| 06/28/2021 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 539 shares
@ $7.78, valued at
$4.2k
|
|
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2020 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 38,750 shares
@ $0 |
|
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2020 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Sold 3,724 shares
@ $0 |
|
| 10/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Sold 622 shares
@ $12.36, valued at
$7.7k
|
|
| 10/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2018 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Acquired 171 shares
@ $21.22, valued at
$3.6k
|
|
| 02/02/2018 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 8,333 shares
@ $0
Granted 33,333 options to buy
@ $22.31, valued at
$743.7k
|
|
| 01/02/2018 |
3/A
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 3/A on Flexion Therapeutics Inc |
| 12/29/2017 |
3
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 3 on Flexion Therapeutics Inc |
| 02/28/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/19/2014 |
4
| Wentworth Kerry (VP, CLinical, Reg, & Quality) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 130,000 options to buy
@ $3, valued at
$390k
|
|
| 09/13/2013 |
4
| Wentworth Kerry (VP, Clinical, Reg, & Quality) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 40,000 options to buy
@ $2.72, valued at
$108.8k
|
|
| 06/17/2013 |
4
| Wentworth Kerry (VP, Clinicial, Reg, & Quality) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 47,500 options to buy
@ $3.61, valued at
$171.5k
|
|
| 01/29/2013 |
4
| Wentworth Kerry (VP, Clin, Reg & Quality) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 694 shares
@ $4.35, valued at
$3k
|
|
| 10/29/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/14/2012 |
4
| Wentworth Kerry (VP Clinical, Reg & Quality) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 5,044 shares
@ $0
Unknown transaction of 1,034 restricted stock units
@ $0 |
|
| 07/30/2012 |
4
| Wentworth Kerry (VP, Clinical, Req & Quality) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 694 shares
@ $4.61, valued at
$3.2k
|
|
| 06/21/2012 |
4
| Wentworth Kerry (VP, Clinical, Reg, & Quality) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 14,153 shares
@ $5.26, valued at
$74.4k
Disposed/sold 14,151 shares
@ $4.99, valued at
$70.6k
Disposed/sold 14,784 shares
@ $5.05, valued at
$74.7k
|
|
| 06/18/2012 |
4
| Wentworth Kerry (VP, Clinical, Reg, & Quality) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 75,000 options to buy
@ $5.34, valued at
$400.5k
Granted 25,000 restricted stock units
@ $0 |
|
| 04/30/2012 |
4
| Wentworth Kerry (VP, Clinical, Reg, & Quality) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 695 shares
@ $6.43, valued at
$4.5k
|
|
|
|
|